A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens
- 1 August 2013
- Vol. 31 (36) , 3732-3738
- https://doi.org/10.1016/j.vaccine.2013.05.073
Abstract
No abstract availableKeywords
Funding Information
- POLYMOD
This publication has 33 references indexed in Scilit:
- Why Do Pertussis Vaccines Fail?Pediatrics, 2012
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussisPLOS ONE, 2010
- Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccineJournal of Medical Microbiology, 2010
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensNew England Journal of Medicine, 2007
- Immunity to Pertussis 5 Years after Booster Immunization during AdolescenceClinical Infectious Diseases, 2007
- Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT StudyThe Journal of Infectious Diseases, 2004
- Serologic Response and Antibody‐Titer Decay in Adults with PertussisClinical Infectious Diseases, 2004
- Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?Emerging Infectious Diseases, 2001
- Antibody Responses to Bordetella pertussis Antigens and Clinical Correlations in Elderly Community ResidentsClinical Infectious Diseases, 2000
- Correlation between Pertussis Toxin IgG Antibodies in Postvaccination Sera and Subsequent Protection against PertussisThe Journal of Infectious Diseases, 2000